ACOG Committee Opinion: number 281, December 2002. Rubella vaccination.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 12468198.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The incidence of rubella decreased from 0.45 per 100,000 in 1990 to 0.1 per 100,000 in 1999. Although there is a nationwide shortage of rubella vaccine, women who are rubella susceptible during pregnancy should receive MMR (measles-mumps-rubella) vaccination postpartum. In October 2001, the federal Centers for Disease Control and Prevention changed the recommendations concerning the pregnancy interval after receiving rubella vaccine. This interval has been reduced from 3 months to 1 month.
Medical subject headings
- Pregnancy Complications, Infectious
- Rubella
- Rubella Syndrome, Congenital
- Rubella Vaccine